284620 Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
284620 FAQ
What was KAINOS MEDICINE INC.’s price range in the past 12 months?
Currently, no data Available
What is KAINOS MEDICINE INC.’s market cap?
KAINOS MEDICINE INC.’s market cap is ₩35.56B.
When is KAINOS MEDICINE INC.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were KAINOS MEDICINE INC.’s earnings last quarter?
KAINOS MEDICINE INC. released its earnings results on May 15, 2026. The company reported -$39.996 earnings per share for the quarter, missing the consensus estimate of N/A by -$39.996.
Is KAINOS MEDICINE INC. overvalued?
According to Wall Street analysts KAINOS MEDICINE INC.’s price is currently Undervalued.
Does KAINOS MEDICINE INC. pay dividends?
KAINOS MEDICINE INC. does not currently pay dividends.
What is KAINOS MEDICINE INC.’s EPS estimate?
KAINOS MEDICINE INC.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does KAINOS MEDICINE INC. have?
KAINOS MEDICINE INC. has 33,086,952 shares outstanding.
What happened to KAINOS MEDICINE INC.’s price movement after its last earnings report?
KAINOS MEDICINE INC. reported an EPS of -$39.996 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of KAINOS MEDICINE INC.?
Currently, no hedge funds are holding shares in KR:284620
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Seoulin Bioscience Co.,Ltd.
―
SYNTEKABIO, INC.
―
Gencurix, Inc.
―
Wonbiogen Co.,Ltd.
―
Oncocross Co., Ltd.
―